AI is transitioning from theory to operational use in pharmacovigilance, but adoption remains uneven. In this interview, Gary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results